Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,245 | -9,135 | -7,129 | -4,975 | -2,570 |
| Depreciation Amortization | 13 | 44 | 33 | 21 | 11 |
| Accounts payable and accrued liabilities | 123 | -74 | -290 | 174 | -105 |
| Other Working Capital | 296 | -324 | -838 | -319 | -96 |
| Other Operating Activity | 271 | 1,675 | 1,526 | 560 | 438 |
| Operating Cash Flow | $-1,543 | $-7,814 | $-6,698 | $-4,539 | $-2,323 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -76 | -53 | -39 | -5 |
| Net Acquisitions | N/A | 71 | 71 | 71 | 71 |
| Investing Cash Flow | $N/A | $-5 | $18 | $32 | $66 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11 | -58 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 10,000 | 10,000 | 8,522 | 4,283 |
| Other Financing Activity | 0 | -1,486 | -1,548 | 0 | 0 |
| Financing Cash Flow | $-11 | $8,456 | $8,452 | $8,522 | $4,283 |
| Beginning Cash Position | 3,227 | 2,591 | 2,591 | 2,591 | 2,591 |
| End Cash Position | 1,673 | 3,227 | 4,363 | 6,606 | 4,617 |
| Net Cash Flow | $-1,554 | $636 | $1,772 | $4,015 | $2,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,543 | -7,814 | -6,698 | -4,539 | -2,323 |
| Capital Expenditure | N/A | -76 | -53 | -39 | -5 |
| Free Cash Flow | -1,543 | -7,891 | -6,751 | -4,578 | -2,328 |